Skip to content
This GLP
By This GLP Editorial Team · Updated October 2026Video visits, separate pharmacy access

Does MEDVidi sell a GLP-1?

MEDvidi offers scheduled online assessment and follow-up, with a weight-care page naming branded GLP-1 options. It is not a bundled medication storefront.

The verdict

The appointment-based model makes clinician contact more concrete than an anonymous checkout. Confirm the weight-care visit price and refill schedule rather than assuming the general mental-health service terms describe every part of the GLP-1 program.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Prescription
Required
Compounded
No

MEDvidi is a broader telehealth service with a dedicated medical weight-loss offering. It lists semaglutide, tirzepatide and liraglutide brands alongside non-GLP-1 options.

  1. Who writes the prescription, and what do they see?

    The company publishes a clinician roster and describes doctors, nurse practitioners and physician assistants. A named roster member is not a promise about who will conduct the patient’s appointment.

    The general service describes an initial video assessment and shorter follow-ups. The weight page also lets patients manage prescriptions and change pharmacies through a portal; availability and prescribing depend on the case.

  2. What happens when the dose goes up?

    Follow-up appointments provide a route to assess response and adjust treatment. Ask how refills are handled between visits and whether a pharmacy shortage requires another paid encounter.

  3. What the price includes

    Published appointment charges and a separate follow-up membership are not medication prices. The weight page advertises no required membership, while the payment terms describe an optional follow-up subscription after an initial visit.

  4. What it claims, and what it cites

    The dedicated weight page names Wegovy, Ozempic, Rybelsus, Zepbound, Mounjaro and Saxenda among options. Indications and eligibility differ; listing a brand does not guarantee its prescription or insurance coverage.

Where it holds up, and where it does not

  • Strength: Video assessment and follow-up described
  • Strength: Provider roster publicly available
  • Limitation: Visit charges do not establish total treatment cost
  • Limitation: Weight-specific follow-up terms need confirmation

What the evidence says about this kind of treatment

The assessment above is about MEDVidi. These are about the drugs it sells, and they are traced to the primary literature.

Right for
Someone who wants scheduled video visits and the ability to manage a prescription through a chosen pharmacy.
Wrong for
Someone who expects the appointment fee to include medication delivery.

The evidence behind what MEDVidi prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

How MEDVidi compares

SellerWho it suitsGo
SkinnyRxReaders choosing tirzepatide, the one line with a published standing rateSee SkinnyRx →
ShedRxReaders willing to telephone a seller and ask which published fee is the real oneSee ShedRx →
RxSpan MDBuyers who want the standing rate, the pharmacy and the prescriber named before signing upSee RxSpan MD →
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Citizen MedsClayaClinic SecretClume HealthCLYR HealthCoivas

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

Check SkinnyRx availability →

Frequently asked

Is the clinician roster my assigned care team?
Not necessarily. Confirm the provider and appointment availability for the weight-loss service.
Does the medication list guarantee access?
No. Prescribing requires clinical review, and pharmacy availability and coverage are separate questions.

Sources for this review

Provider information checked . Terms can change.

This GLP Editorial TeamPublisher · Updated October 2026

How this was assessed. The four questions above are answered from MEDVidi’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.